Chronic exposure to Ro20-1724 protects dopaminergic neurons in vitro against the neurotoxic action of N-methyl-D-aspartate and 1-methyl-4-phenylpyridinium

Brain Research

Volumn 753, Issue 2, 1997, Pages 335-339

  Dickie, Brian G M ^a   Greenfield, Susan A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

1 methyl 4 phenylpyridinium; cell culture; cyclic adenosine monophosphate; dopaminergic neuron; N methyl D aspartate; neurotoxicity

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; CYCLIC AMP; N METHYL DEXTRO ASPARTIC ACID; NEUROPROTECTIVE AGENT; PHOSPHODIESTERASE INHIBITOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; NEUROTOXICITY; NEWBORN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; 4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; ANIMALS; DOPAMINE; DOPAMINE AGENTS; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PHOSPHODIESTERASE INHIBITORS; RATS; TIME FACTORS;

EID: 0031564632     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00152-2     Document Type: Article

References (37)

1. Beavo, J.A., Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms, Physiol. Rev., 75 (1995) 725-748.
2. Brouillet, E. and Beal, M.F., NMDA antagonists partially protect against MPTP induced neurotoxicity in mice, Neuroreport, 4 (1993) 387-390.
3. Buckmaster, E.A. and Tolkovsky, A.M., Expression of cyclic AMP-dependent protein kinase (PKA) catalytic subunit from a herpes simplex virus vector extends the survival of rat sympathetic neurons in the absence of NGF, Eur. J. Neurosci., 6 (1994) 1316-1327.
4. Cerne, R., Rusin, K.I. and Randic, M., Enhancement of the N-methyl-D-aspartate response in spinal dorsal horn neurons by cAMP-dependent protein kinase, Neurosci. Lett., 161 (1993) 124-128.
5. Chacon, J.A., Chedekel, M.R., Lane, E.J. and Truscott, T.G., Chemically-induced Parkinson's disease: intermediates in the oxidation and reduction of the 1-methyl-4-phenyl-2,3-dihydropyridinium ion and its deprotonated form, Biochem. Biophys. Res. Commun., 158 (1989) 63-71.
6. Connop, B.P., Boegman, R.J., Jhamandas, K. and Beninger, R.J., Excitotoxic action of NMDA agonists on nigrostriatal neurons: modulation by inhibition of nitric oxide synthesis, Brain Res., 676 (1995) 124-132.
7. De Erausquin, G.A., Costa, E. and Hanbauer, I., Calcium homeostasis, free radical formation and trophic factor dependence mechanisms in Parkinson's disease, Pharmacol Rev., 46 (1994) 467-482.
8. +-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport, Brain Res., 715 (1996) 1-8.
9. Dickie, B.G.M., Holmes, C. and Greenfield, S.A., Neurotoxic and neurotrophic effects of chronic N-methyl-D-aspartate exposure upon mesencephalic dopaminergic neurons in organotypic culture, Neuroscience, 72 (1996) 731-741.
10. Finiels-Marlier, F., Marini, A.M., Williams, P. and Paul, S.M., The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro, J. Neurochem., 60 (1993) 1968-1971.
11. Gahwiler, B.H., Thompson, S.M., Audinat, E. and Robertson, R.T., Organotypic slice cultures of neural tissue. In G. Banker and K. Goslin (Eds.), Culturing Nerve Cells, M.I.T. Press, Cambridge, 1991, pp. 379-411.
12. Garthwaite, J. and Garthwaite, G., Mechanisms of excitatory amino acid neurotoxicity in rat brain slices, Adv. Exp. Med. Biol., 268 (1990) 505-518.
13. + -induced degeneration, J. Neurosci. Res., 32 (1992) 190-201.
14. Huang, C.C., Tsai, J.J. and Gean, P.W., Enhancement of NMDA receptor-mediated synaptic potential by isoproterenol is blocked by Rp-adenosine 3′,5′-cyclic monophosphothioate, Neurosci. Lett., 161 (1993) 207-210.
15. Hulley, P., Hartikka, J., Abedel'Al, S., Engels, P., Buerki, H.-R., Wiederhold, K-H., Müller, T., Kelly, P., Lowe, D. and Lübbert, H., Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo, Eur. J. Neurosci., 7 (1995) 2341-2440.
16. Javitch, J.A., D'Amato, R.J., Strittmatter, S.M. and Snyder, S.H., Parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of metabolite 1-methyl-4-phenylpyridinium by dopamine neurons explains toxicity. Proc. Natl. Acad. Sci. USA, 82 (1985) 2173-2177.
17. Jones, S.A., Holmes, C., Budd, T.C. and Greenfield, S.A., The effect of acetylcholinesterase on outgrowth of dopaminergic neurons in organotypic slice culture, Cell Tissue Res., 279 (1995) 323-330.
18. Kikuchi, S. and Kim, S.U., Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture, J. Neurosci. Res., 36 (1993) 558-569.
19. Lange, K.W., Youdim, M.B.H. and Reiderer, P., Neurotoxicity and neuroprotection in Parkinson's disease, J. Neural Transm. (Suppl.), 38 (1992) 27-44.
20. Leviel, V., Guibert, B., Mallet, J. and Faucon-Biguet, N., Induction of tyrosine hydroxylase in the rat substantia nigra by local injection of forskolin, J. Neurosci. Res., 30 (1991) 427-432.
21. Lindsay, R.M., Altar, C.A., Cedarbaum, J.M., Hyman, C. and Wiegand, S.J., The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease, Exp. Neurol., 124 (1993) 103-118.
22. Michel, P.P. and Agid, Y., Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons, J. Neurochem., 67 (1996) 1633-1642.
23. Onalow, C.W., A scientific rationale for protective therapy in Parkinson's disease, J. Neural Transm., 91 (1993) 161-180.
24. Orrenius, S. and Nicotera, P., The calcium ion and cell death, J. Neural Transm. (Suppl.), 43 (1994) 1-11.
25. Ossowska, K., The role of excitatory amino acids in experimental models of Parkinson's disease, J. Neural Transm. (Park. Dis. Dement. Sect.), 8 (1994) 39-71.
26. Østergaard, K., Schou, J.P. and Zimmer, J., Rat ventral mesencephalon grown as organotypic slice cultures and co-cultured with striatum, hippocampus and cerebellum, Exp. Brain Res., 82 (1990) 547-565.
27. +, Biochem. Biophys. Res. Commun., 134 (1986) 743-748.
28. Rukenstein, A., Rydel, R.E. and Greene, L.A., Multiple agents rescue PC12 cells from serum-free cell death by translation and transcription-independent mechanisms, J. Neurosci., 11 (1991) 2552-2563.
29. Salach, J.I., Singer, T.P., Castgnoli, N. and Trevor, A., Oxidation of neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP, Biochem. Biophys. Res. Commun., 125 (1984) 831-835.
30. Sheppard, H., Wiggan, G. and Tsien, W.H., Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues, Adv. Cyc. Nucl. Res., 1 (1972) 103-112.
31. +): reductive activation by NADPH cytochrome P-450 reductase, Biochem. Biophys. Res. Commun., 135 (1986) 583-588.
32. Sklair-Tavron, L. and Segal, M., Neurotrophic effects of cAMP generating systems on central noradrenergic neurons, Brain Res., 614 (1993) 257-269.
33. Sonsalla, P.K., Zeevalk, G.D., Manzino, L., Giovanni, A. and Nicklas, W.J., MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats, J. Neurochem., 58 (1992) 1979-1982.
34. +) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss, Neurobiol. Aging, 14 (1993) 295-301.
35. Trump, B.F. and Berezesky, I.K., Calcium-mediated cell injury and cell death, Fed. Am. Socs. Exp. Biol. J., 9 (1995) 219-228.
36. + neurotoxicity by N-methyl-D-aspartate antagonists, Nature, 349 (1991) 414-418.
37. Vaglini, F., Fascetti, F., Fornai, F., Maggio, R. and Corsini, G.U., (+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice, Brain Res., 668 (1994) 194-203.